HC Wainwright & Co. Downgrades Caribou Biosciences to Neutral

Benzinga · 2d ago
HC Wainwright & Co. analyst Robert Burns downgrades Caribou Biosciences (NASDAQ:CRBU) from Buy to Neutral.